Evofem Biosciences, Inc.EVFMOTCMARKET
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank33
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P33
Within normal range
vs 3Y Ago
-0.4x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | -37.22% |
| 2023 | -88.26% |
| 2022 | -24.44% |
| 2021 | 94.30% |
| 2020 | -23.30% |
| 2019 | -48.80% |
| 2018 | 84.44% |
| 2017 | 257.81% |
| 2016 | -80.88% |
| 2015 | 564.94% |